查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2047051

全球高級傷口護理市場－產業規模、佔有率、趨勢、機會和預測：按產品、應用、最終用戶、地區和競爭對手分類，2021-2031年

Advanced Wound Care Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球先進創傷護理市場預計將從 2025 年的 112.9 億美元成長到 2031 年的 151.5 億美元，複合年成長率為 5.02%。

該市場涵蓋親水膠體、藻酸鹽和負壓傷口治療 (NPWT) 設備等專業治療產品，這些產品旨在透過創造最佳的濕潤癒合環境來治療複雜的急性和慢性傷口。推動該市場成長的主要因素是全球慢性文明病（尤其是糖尿病）盛行率的不斷上升。這些疾病是導致難以癒合的潰瘍的重要原因。根據國際糖尿病聯盟 (IDF) 預測，到 2025 年，全球將有約 5.89 億成年人患有糖尿病，這將顯著擴大需要有效且長期傷口管理解決方案的患者群體。儘管市場需求強勁，但由於這些先進治療方法與傳統敷料相比成本較高，該市場面臨巨大的障礙。發展中地區嚴格的報銷政策往往會加劇這種經濟限制，導致患者難以獲得這些至關重要的治療。這些限制常常迫使醫療服務提供者選擇療效較差但成本較低的替代方案，最終阻礙了市場的進一步擴張。

市場概覽
預測期 2027-2031
市場規模：2025年 112.9億美元
市場規模：2031年 151.5億美元
複合年成長率：2026-2031年 5.02%
成長最快的細分市場 居家醫療
最大的市場 北美洲

市場促進因素

全球人口老化是市場擴張的主要驅動力，從根本上改變了對治療方案的需求。隨著老齡化，皮膚彈性下降、血管功能受損、細胞再生延遲等生理變化會逐漸發生，顯著增加靜脈潰瘍和壓瘡等慢性疾病的風險。這些人口結構變化促使人們從傳統的敷料轉向能夠控制滲出液、促進組織修復的主動治療方法，尤其對於健康狀況不穩定的患者而言。世界衛生組織（世衛組織）2025年2月發布的報告《老化：全球人口》預測，到2030年，全球60歲及以上人口預計將達到14億，這迫切需要可擴充性的、長期的傷口管理策略，以應對老齡化皮膚的複雜性。同時，創傷護理產品的技術進步，特別是生物製藥和細胞/組織產品的開發，也是市場成長的關鍵驅動力。魚皮移植和生物活性敷料等創新產品因其能夠加速難治性傷口（對傳統治療方法無效）的傷口縫合而日益受到青睞。這些先進技術的快速普及得益於近期的產業趨勢。例如，根據科樂普公司（Coloplast A/S）於2025年11月發布的2024/25會計年度年度報告，該公司傷口和組織修復部門Kerecis實現了20%的成長率，這反映了富含脂質的生物製劑迅速獲得市場認可。對較佳治療效果的實質需求支撐著該產業的韌性，康維德集團（Convatec Group Plc）的例子也進一步印證了這一點。該公司於2025年2月發布的2024會計年度年度報告及財務業績顯示，其高級傷口護理部門的銷售額成長了6.8%，達到7.43億美元，表明這些高科技治療方法的商業性勢頭仍在持續。

市場挑戰

專業治療產品的高昂成本是全球先進創傷護理市場成長的主要障礙。負壓傷口治療和生物活性敷料等先進解決方案的價格遠高於傳統的傷口管理方案。這種顯著的價格差異構成了巨大的經濟負擔，尤其是在預算有限的醫療體系中。因此，支付方和保險公司經常實施嚴格的報銷政策來控制支出，限制了醫療服務提供者開立這些有效但昂貴的治療方法的能力。當報銷被拒絕或受到限制時，臨床醫生往往被迫使用價格較低但療效較差的替代方案，這直接降低了先進創傷護理產品製造商的採用率和收入潛力。近期關於傷口管理經濟影響的數據清楚地顯示了這種經濟負擔的嚴重性。根據日本創傷治療學會官方期刊《傷口護理進展》報道，到2025年，美國醫療保險系統治療慢性傷口的費用預計將達到每年225億美元。如此龐大的總成本促使支付方實施嚴格的承保範圍限制和支付標準。為了遏制支出激增，報銷途徑收緊，先進創傷護理產品的商業性覆蓋範圍實際上受到限制，阻礙了整體市場成長。

市場趨勢

穿戴式和可攜式負壓傷口治療 (NPWT) 裝置的普及正在從根本上改變市場格局，推動治療模式從住院轉向居家照護。這些緊湊、通常為一次性使用且無需儲罐的系統使患者能夠在繼續治療的同時保持行動自由，有效滿足了縮短住院時間、降低成本的門診治療需求。這種以患者為中心的技術進步正在產生顯著的商業性動力，尤其是在醫療系統日益重視遠端系統管理能力的情況下。近期財報結果有力地印證了這個趨勢。根據史密斯醫療 (Smith+Nephew) 於 2025 年 2 月發布的“2024 年第四季度及全年業績報告”，該公司“先進傷口護理設備”部門的核心銷售額成長了 20.6%，主要得益於 PICO 一次性負壓系統的加速普及。同時，在減少醫療廢棄物環境影響的監管壓力不斷增加以及醫療機構需求的推動下，該行業對永續和環保型創傷護理材料的關注度顯著提高。製造商正積極重新設計產品生命週期，以採用可再生原料並最大限度地減少對塑膠的依賴，從而將永續性從企業社會責任的簡單指標轉變為關鍵的競爭優勢。這種與綠色製造原則的策略契合，為產業領導者帶來了可觀的財務表現。例如，根據 Molnlike Healthcare 於 2025 年 4 月發布的 2024 會計年度年度報告，其銷售額成長了 7.4%。這一成長得益於對永續醫療保健解決方案和脫碳業務流程的策略性投資。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球先進傷口護理市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品種類（保濕、抗菌、活性成分）
    • 按應用（慢性傷口、急性傷口）
    • 依最終使用者（醫院、專科診所、居家醫療等）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美高階傷口護理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲先進傷口護理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區先進傷口護理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲先進傷口護理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲先進傷口護理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球先進傷口護理市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Convatec Group PLC
  • Molnlycke AB
  • B. Braun SE
  • 3M Company
  • Urgo Group
  • Coloplast Corp
  • Integra LifeSciences Corporation
  • Medline Industries, LP.
  • Boston Scientific Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 14955

The Global Advanced Wound Care Market is projected to expand from USD 11.29 Billion in 2025 to USD 15.15 Billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) of 5.02%. This market encompasses specialized therapeutic products, such as hydrocolloids, alginates, and negative pressure wound therapy devices, which are specifically designed to treat complex acute and chronic wounds by fostering an optimal moist healing environment. A primary catalyst for this market's growth is the increasing worldwide prevalence of chronic lifestyle diseases, particularly diabetes, which significantly contributes to the incidence of ulcers that are difficult to heal. As reported by the International Diabetes Federation, approximately 589 million adults globally were living with diabetes in 2025, thereby creating a substantial and expanding patient demographic that requires effective, long-term wound management solutions. Despite the strong demand, the market faces a considerable hurdle due to the elevated cost of these advanced therapies compared to conventional dressings. This financial constraint is often intensified by restrictive reimbursement policies in developing regions, which consequently limit patient access to these crucial treatments. Such limitations often compel healthcare providers to opt for less effective, lower-cost alternatives, ultimately hindering the broader expansion of the market.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 11.29 Billion
Market Size 2031USD 15.15 Billion
CAGR 2026-20315.02%
Fastest Growing SegmentHome Healthcare
Largest MarketNorth America

Market Driver

The escalating global geriatric population stands as a principal driver for market expansion, fundamentally transforming the demand for therapeutic solutions. As individuals age, physiological changes like diminished skin elasticity, impaired vascular function, and slower cellular regeneration substantially heighten their susceptibility to chronic conditions such as venous leg ulcers and pressure injuries. This demographic shift necessitates a move away from traditional dressings towards active therapies capable of managing exudate and promoting tissue repair in compromised patients. According to the World Health Organization's February 2025 'Ageing: Global population' report, the number of people aged 60 and older worldwide is anticipated to reach 1.4 billion by 2030, highlighting an urgent need for scalable, long-term wound management strategies that address the complexities of aging skin. Concurrently, technological advancements in wound care products are instrumental in driving market growth, particularly through the development of biologics and cellular tissue products. Innovations like fish-skin grafts and bioactive dressings are increasingly favored for their capacity to accelerate closure in stubborn wounds where conventional treatments have failed. The rapid adoption of these sophisticated technologies is underscored by recent industry performance; for example, Coloplast A/S's November 2025 'Annual Report 2024/25' indicated that its Kerecis wound and tissue repair segment achieved a 20% growth rate, reflecting the swift market acceptance of lipid-rich biologic solutions. This specific demand for enhanced efficacy bolsters the sector's resilience, as further demonstrated by Convatec Group Plc, whose February 2025 'Annual Report and Accounts 2024' reported an Advanced Wound Care revenue increase of 6.8% to $743 million, signifying the sustained commercial momentum of these high-tech interventions.

Market Challenge

The substantial cost of specialized therapeutic products presents a primary impediment to the growth of the Global Advanced Wound Care Market. Advanced solutions, including negative pressure wound therapy and bioactive dressings, are considerably more expensive than traditional wound management options. This significant price difference creates a major financial barrier, especially in healthcare systems with limited budgets. Consequently, payers and insurance providers frequently implement stringent reimbursement policies to manage expenditures, which restricts healthcare providers' ability to prescribe these effective yet costly treatments. When reimbursement is either denied or capped, clinicians are often forced to use more affordable, but less effective, alternatives, directly reducing the adoption rates and revenue potential for manufacturers of advanced wound care products. The extent of this financial burden is clearly illustrated by recent data detailing the economic impact of wound management. According to Advances in Wound Care, the official journal of the Wound Healing Society, the estimated annual cost of treating chronic wounds within the U.S. Medicare system alone reached $22.5 billion in 2025. This immense aggregate cost motivates payers to enforce rigorous coverage limitations and strict payment criteria. As reimbursement pathways become narrower to mitigate these escalating expenditures, the commercial reach of advanced wound care products is effectively constrained, thereby hindering broader market growth.

Market Trends

The widespread adoption of wearable and portable negative pressure wound therapy (NPWT) devices is fundamentally transforming the market by enabling a crucial shift from inpatient facilities to home-based care. These compact, often single-use, and canister-free systems allow patients to maintain mobility while undergoing continuous therapy, effectively addressing the need for cost-efficient outpatient solutions that reduce hospital stays. This technological evolution toward patient-centric designs is generating substantial commercial traction, particularly as healthcare systems increasingly prioritize remote management capabilities. Strong evidence for this trend is found in recent financial results; according to Smith+Nephew's February 2025 'Fourth Quarter and Full Year 2024 Results', the company's Advanced Wound Devices segment reported an underlying revenue growth of 20.6%, largely driven by the accelerated uptake of its PICO single-use negative pressure system. In parallel, the sector is demonstrating a significant focus on sustainable and eco-friendly wound care materials, prompted by escalating regulatory pressures and institutional demand to reduce the environmental impact of medical waste. Manufacturers are proactively redesigning product lifecycles to incorporate renewable inputs and minimize reliance on plastics, thus transitioning sustainability from a mere corporate responsibility metric into a key competitive differentiator. This strategic alignment with green manufacturing principles is correlating with positive financial outcomes for leading industry players. For instance, Molnlycke Health Care's April 2025 'Annual report 2024' indicated a net sales increase of 7.4%, a growth rate bolstered by its strategic investments in sustainable healthcare solutions and decarbonized operational processes.

Key Market Players

  • Convatec Group PLC
  • Molnlycke AB
  • B. Braun SE
  • 3M Company
  • Urgo Group
  • Coloplast Corp
  • Integra LifeSciences Corporation
  • Medline Industries, LP.
  • Boston Scientific Corporation

Report Scope

In this report, the Global Advanced Wound Care Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Advanced Wound Care Market, By Product

  • Moist
  • Antimicrobial
  • Active

Advanced Wound Care Market, By Application

  • Chronic Wounds
  • Acute Wounds

Advanced Wound Care Market, By End User

  • Hospitals
  • Specialty Clinics
  • Home Healthcare
  • Others

Advanced Wound Care Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Advanced Wound Care Market.

Available Customizations:

Global Advanced Wound Care Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Advanced Wound Care Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Moist, Antimicrobial, Active)
    • 5.2.2. By Application (Chronic Wounds, Acute Wounds)
    • 5.2.3. By End User (Hospitals, Specialty Clinics, Home Healthcare, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Advanced Wound Care Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Advanced Wound Care Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Advanced Wound Care Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Advanced Wound Care Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Advanced Wound Care Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Advanced Wound Care Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. France Advanced Wound Care Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Advanced Wound Care Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Advanced Wound Care Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Advanced Wound Care Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia Pacific Advanced Wound Care Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Advanced Wound Care Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Advanced Wound Care Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Advanced Wound Care Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Advanced Wound Care Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Advanced Wound Care Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Middle East & Africa Advanced Wound Care Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Advanced Wound Care Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Advanced Wound Care Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Advanced Wound Care Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. South America Advanced Wound Care Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Advanced Wound Care Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Advanced Wound Care Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Advanced Wound Care Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Advanced Wound Care Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Convatec Group PLC
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Molnlycke AB
  • 15.3. B. Braun SE
  • 15.4. 3M Company
  • 15.5. Urgo Group
  • 15.6. Coloplast Corp
  • 15.7. Integra LifeSciences Corporation
  • 15.8. Medline Industries, LP.
  • 15.9. Boston Scientific Corporation

16. Strategic Recommendations

17. About Us & Disclaimer